MyAverix Finance
F · Healthcare
Lobe Sciences Ltd. (LOBE)
Biotechnology
Lobe Sciences Ltd. (LOBE) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $13.68M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LOBE
Lobe Sciences Ltd. (LOBE) — FAQ
What is Lobe Sciences Ltd.'s market cap?
Lobe Sciences Ltd. (LOBE) has a reported market cap of $13.68M (data as of 2026-03-30).
What is LOBE's P/E ratio?
The price-to-earnings (P/E) ratio for Lobe Sciences Ltd. (LOBE) is 18.00 (data as of 2026-03-30).
Does Lobe Sciences Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Lobe Sciences Ltd. (LOBE). Check the MyAverix Finance app for the latest dividend data.
What sector is Lobe Sciences Ltd. in?
Lobe Sciences Ltd. (LOBE) is classified in the Healthcare sector (Biotechnology industry).
What exchange is LOBE listed on?
LOBE is listed on F.
What is Lobe Sciences Ltd.'s net margin?
Lobe Sciences Ltd. (LOBE) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.